dapsone has been researched along with trimethoprim in 101 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 43 (42.57) | 18.7374 |
| 1990's | 27 (26.73) | 18.2507 |
| 2000's | 15 (14.85) | 29.6817 |
| 2010's | 16 (15.84) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Genther, CS; Smith, CS | 1 |
| Queener, SF | 1 |
| Doman, TN; McGovern, SL; Seidler, J; Shoichet, BK | 1 |
| Bartels, R; Hänsel, W; Kunz, B; Lehwark-Yvetot, G; Otzen, T; Schaper, KJ; Seydel, JK; Wempe, EG | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Bury, L; Caspers, P; Gaucher, B; Heim, J; Schmitt-Hoffmann, A; Shapiro, S; Siegrist, S; Thenoz, L; Urwyler, H | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Bera, S; Mondal, D | 1 |
| Hlaing, N; Htun Nyun, R; Kyi, KK; Myint, T; Tin, F; U, T | 1 |
| Kakande, I | 1 |
| Davidson, DE; Hickman, RL; Johnsen, DO; Kinnamon, KE; Tanticharoenyos, P | 1 |
| Havas, L | 1 |
| Coleman, MD; Park, BK; Russell, RM; Tingle, MD | 1 |
| Laifer, G; Rüttimann, S | 1 |
| Feinberg, J; Sattler, FR | 1 |
| Costantino, M | 1 |
| Kwok, RY; Lambertus, MW; Mulligan, ME | 1 |
| Dhople, AM; Jagannathan, R; Mahadevan, PR; Rosenfeld, M; Seydel, JK; Wempe, EG | 1 |
| Crosby, WH | 1 |
| Benowitz, N; Hopewell, PC; Lee, B; Leoung, G; Medina, I; Mills, J; Modin, G; Wofsy, CB | 1 |
| Montgomery, AB | 2 |
| Girard, PM | 1 |
| Benowitz, NL; Jacob, P; Lee, BL; Medina, I; Mills, J; Wofsy, CB | 1 |
| Durfee, D; Kurtin, PJ; McKinsey, DS | 1 |
| Hopewell, PC; Hughes, W; Leoung, GS; Mills, J; Wofsy, C | 1 |
| Kovacs, JA; Masur, H | 1 |
| Fischl, MA | 1 |
| Hauptman, SP; Wordell, CJ | 1 |
| Clarkson, AB; Rosenberg, C; Williams, DE | 1 |
| Cushion, MT; Foy, JM; Kim, CK; Linke, MJ; Walzer, PD | 1 |
| Hughes, WT | 1 |
| Hopewell, PC; Hughes, WT; Leoung, G; Medina, I; Mills, J; Wofsy, C | 1 |
| Christie, PR; Goldberg, DJ; Green, ST; Kennedy, DH; Leach, J | 1 |
| el Sid, MA; Gumaa, SA; Mahgoub, ES | 1 |
| Hughes, WT; Jacobus, DP; Smith, BL | 1 |
| Andrade, R; Bonifaz, A; Messina, M; Saúl, A | 1 |
| Himmunknan, P; Piamphongsant, T; Sirimachan, S | 1 |
| Edelson, PJ; Friedman-Kien, A; Metroka, CE | 1 |
| Catterall, JR; Potasman, I; Remington, JS | 1 |
| Cushion, MT; Linke, MJ; Stanforth, D; Walzer, PD | 1 |
| Vischer, WA | 1 |
| Bowman, JE; Carson, PE; Frischer, H; Kass, L; Richard, L; Rieckmann, KH; Willerson, D | 1 |
| Geiman, QM; Schnell, JV; Siddiqui, WA | 1 |
| Freerksen, E; Rosenfeld, M | 2 |
| Rohde, R | 1 |
| Botelho, A | 1 |
| Botha, D | 1 |
| Laing, AB | 1 |
| Hughes, WT; Smith, BL | 1 |
| Rosenfeld, M; Seydel, JK; Wempe, EG | 1 |
| Biagini, RE; Martínez, TE; Museli, A; Sarmiento Villa, H | 1 |
| Richter, M; Seydel, JK; Wempe, E | 1 |
| Dankert, W; Hartman, PG; Mehlhorn, H; Then, RL | 1 |
| Hughes, WT; Killmar, JT; Oz, HS | 1 |
| Arsenijevic, D; Chang, HR; Comte, R; Pechère, JC; Polak, A; Then, RL | 1 |
| Lizasoain, M; Lumbreras, C; Pastor, C | 1 |
| Glick, M; Muzyka, BC | 1 |
| Seydel, JK | 1 |
| Foy, J; Steele, P; Walzer, PD; White, M | 1 |
| Lang, W; Moss, A; Osmond, D; Page-Bodkin, K; Winkelstein, W | 1 |
| Fraser-Smith, EB; Freitas, VR; Matthews, TR | 1 |
| Kuster, H; Lüthy, R; Opravil, M; Russi, EW; Siegenthaler, W; Speich, R; Teuscher, AU; Theiler, R | 1 |
| Allegra, CJ; Kovacs, JA; Martinez, A | 1 |
| Korraa, H; Saadeh, C | 1 |
| Gambertoglio, JG; Lee, BL; Makrides, V; Safrin, S | 1 |
| Angehrn, P; Hartman, PG; Locher, HH; Schlunegger, H; Then, RL | 1 |
| Brun-Pascaud, M; Chau, F; Derouin, F; Garry, L; Girard, PM; Jacobus, D | 1 |
| Bernauer, W; Font, RL; Messmer, EP; Moll, C; Ruggli, GM; Weber, R | 1 |
| Dhople, AM | 3 |
| McPartlin, DW; Patel, SK; Philpott, JM | 1 |
| Antin, JH; Bernardo, MV; King, C; Vasconcelles, MJ; Weller, EA | 1 |
| Beard, CB; Carter, JL; del Rio, C; Hightower, A; Huang, L; Le, T; Lee, S; Navin, TR; Pieniazek, NJ; Rimland, D | 1 |
| Elmahallawy, M; Horsfield, C; Praveen, CV; Terry, RM | 1 |
| Atzori, C; Benfield, T; Crothers, K; Helweg-Larsen, J; Huang, L; Miller, R; Rabodonirina, M | 1 |
| Bellamy, R | 1 |
| Mannion, C; McDonald, M; Rafter, P | 1 |
| Giordano, TP; Serpa, JA; Villarreal-Williams, E | 1 |
| Botitsi, E; Economou, A; Petraki, O; Tsipi, D | 1 |
| Brandão, MAF; Ferreira, AO; Patrício, FB; Polonini, HC; Raposo, NRB; Silva, SL | 1 |
| Bilandžić, N; Božić, Đ; Kolanović, BS; Sedak, M; Varenina, I; Varga, I; Đokić, M | 1 |
15 review(s) available for dapsone and trimethoprim
| Article | Year |
|---|---|
New drug developments for opportunistic infections in immunosuppressed patients: Pneumocystis carinii.
Topics: Animals; Drug Design; Humans; Immunosuppression Therapy; Molecular Structure; Opportunistic Infections; Pneumonia, Pneumocystis; Structure-Activity Relationship | 1995 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
Recent developments in the therapy and management of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1989 |
Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome: pathophysiology, therapy, and prevention.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Diet; Drug Combinations; Humans; Oxygen Inhalation Therapy; Pentamidine; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim | 1989 |
Pneumocystis carinii pneumonia: therapy and prophylaxis.
Topics: Acquired Immunodeficiency Syndrome; Anti-Bacterial Agents; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Quinazolines; Recurrence; Sulfadiazine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1988 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antiprotozoal Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate; Zidovudine | 1988 |
Prevention of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Aerosols; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimethamine; Recurrence; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
[Current alternatives in the treatment of Pneumocystis carinii pneumonia in patients with AIDS].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Eflornithine; Humans; Naphthoquinones; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimetrexate | 1994 |
In vitro and in vivo results of brodimoprim and analogues alone and in combination against E. coli and mycobacteria.
Topics: Dapsone; Dihydropteroate Synthase; Escherichia coli; Escherichia coli Infections; Humans; Leprosy; Mycobacterium; Mycobacterium Infections; Tetrahydrofolate Dehydrogenase; Trimethoprim | 1993 |
Options in the management of pneumonia caused by Pneumocystis carinii in patients with acquired immune deficiency syndrome and intolerance to trimethoprim/sulfamethoxazole.
Topics: Adrenal Cortex Hormones; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antifungal Agents; Atovaquone; Clindamycin; Dapsone; Drug Combinations; Drug Hypersensitivity; Drug Resistance, Microbial; Humans; Leucovorin; Naphthoquinones; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1996 |
An unusual case of Pneumocystis carinii presenting as an aural mass.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Ear Diseases; Ear, External; Humans; Magnetic Resonance Imaging; Male; Pneumocystis; Pneumocystis Infections; Tomography, X-Ray Computed; Trimethoprim | 1999 |
Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dapsone; Ear Neoplasms; Ear, Middle; Humans; Male; Pneumocystis Infections; Polyps; Sulfamethoxazole; Tomography, X-Ray Computed; Trimethoprim | 2002 |
Dihydropteroate synthase gene mutations in Pneumocystis and sulfa resistance.
Topics: Anti-Infective Agents; Dapsone; Dihydropteroate Synthase; Drug Resistance, Fungal; Gene Expression; Humans; Mutation; Pneumocystis carinii; Pneumonia, Pneumocystis; Risk Factors; Sulfamethoxazole; Sulfones; Trimethoprim | 2004 |
Pneumocystis pneumonia in people with HIV.
Topics: Anti-Infective Agents; Antiprotozoal Agents; Atovaquone; Clindamycin; Dapsone; Drug Therapy, Combination; HIV Infections; Humans; Pentamidine; Pneumonia, Pneumocystis; Primaquine; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
9 trial(s) available for dapsone and trimethoprim
| Article | Year |
|---|---|
Chloroquine-resistant malaria in Burma.
Topics: Chloroquine; Clinical Trials as Topic; Dapsone; Drug Resistance, Microbial; Humans; Malaria; Myanmar; Plasmodium falciparum; Pyrimethamine; Quinine; Sulfadoxine; Sulfamethoxypyridazine; Trimethoprim | 1975 |
[Successful treatment of HIV-associated pneumocystis carinii pneumonia with dapsone plus trimethoprim].
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Ambulatory Care; Dapsone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Pneumonia, Pneumocystis; Prospective Studies; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. A controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Chemical and Drug Induced Liver Injury; Dapsone; Double-Blind Method; Drug Combinations; Female; Humans; Male; Neutropenia; Pentamidine; Pneumonia, Pneumocystis; Random Allocation; Survival Rate; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with the acquired immunodeficiency syndrome (AIDS). Evidence of drug interactions.
Topics: Acetylation; Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Phenotype; Pneumonia, Pneumocystis; Prospective Studies; Random Allocation; Sulfamethoxazole; Trimethoprim | 1989 |
Treatment and prophylaxis of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Antiprotozoal Agents; Clinical Trials as Topic; Dapsone; Drug Combinations; Humans; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate; Zidovudine | 1988 |
Pneumocystis carinii pneumonia in the patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bronchoscopy; Clinical Trials as Topic; Dapsone; Drug Combinations; Drug Therapy, Combination; Eflornithine; Humans; Male; Ornithine; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Pyrimethamine; Sulfadiazine; Sulfamethoxazole; Therapeutic Irrigation; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Combinations of 4-aminobenzoic acid competitors and dihydrofolate dehydrogenase inhibitors in the chemotherapy of malaria. A commentary.
Topics: Africa; Antimalarials; Asia; Chloroquine; Clinical Trials as Topic; Dapsone; Drug Evaluation; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Malaria; Pyrimethamine; Trimethoprim | 1974 |
Zidovudine, trimethoprim, and dapsone pharmacokinetic interactions in patients with human immunodeficiency virus infection.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Combinations; Humans; Male; Trimethoprim; Zidovudine | 1996 |
Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosol Propellants; Aged; Antifungal Agents; Bone Marrow Transplantation; Cohort Studies; Combined Modality Therapy; Dapsone; Drug Evaluation; Female; Graft vs Host Disease; Hematologic Neoplasms; Humans; Infections; Male; Middle Aged; Pentamidine; Pneumocystis Infections; Retrospective Studies; Sulfamethoxazole; Survival Rate; Trimethoprim | 2000 |
78 other study(ies) available for dapsone and trimethoprim
| Article | Year |
|---|---|
Antifolate studies. Activities of 40 potential antimalarial compounds against sensitive and chlorguanide triazine resistant strains of folate-requiring bacteria and Escherichia coli.
Topics: Animals; Antimalarials; Bacteria; Drug Resistance, Microbial; Escherichia coli; Folic Acid; Folic Acid Antagonists; Malaria; Mice; Plasmodium berghei; Triazines | 1977 |
Identification and prediction of promiscuous aggregating inhibitors among known drugs.
Topics: Antifungal Agents; beta-Lactamase Inhibitors; Chemical Phenomena; Chemistry, Physical; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Molecular; Molecular Conformation; Scattering, Radiation; Structure-Activity Relationship | 2003 |
Folate-synthesizing enzyme system as target for development of inhibitors and inhibitor combinations against Candida albicans-synthesis and biological activity of new 2,4-diaminopyrimidines and 4'-substituted 4-aminodiphenyl sulfones.
Topics: Aminopyridines; Animals; Antifungal Agents; Candida albicans; Dihydropteroate Synthase; Drug Combinations; Drug Resistance, Multiple, Fungal; Folic Acid Antagonists; Microbial Sensitivity Tests; Mutation; Quantitative Structure-Activity Relationship; Rats; Sulfones; Tetrahydrofolate Dehydrogenase | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
In vitro and in vivo properties of dihydrophthalazine antifolates, a novel family of antibacterial drugs.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Enterococcus; Folic Acid Antagonists; Haemophilus influenzae; HeLa Cells; Humans; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Moraxella catarrhalis; Mycobacterium avium; Phthalazines; Polymerase Chain Reaction; Streptococcus pneumoniae; Tetrahydrofolate Dehydrogenase; Trimethoprim | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Treatment of mycetoma.
Topics: Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Mycetoma; Streptomycin; Sulfamethoxazole; Trimethoprim | 1977 |
Treatment of mycetoma with a combination of dapsone and co-trimoxazole.
Topics: Adult; Dapsone; Drug Combinations; Drug Therapy, Combination; Humans; Male; Mycetoma; Sulfamethoxazole; Trimethoprim | 1979 |
Evaluating new antimalarial drugs against trophozoite induced Plasmodium cynomolgi malaria in rhesus monkeys.
Topics: Amodiaquine; Animals; Antimalarials; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Tolerance; Haplorhini; Macaca mulatta; Malaria; Phenanthrenes; Primaquine; Prodigiosin; Pyrimethamine; Quinine; Sulfadiazine; Sulfadimethoxine; Sulfalene; Trimethoprim | 1976 |
[The treatment of various deep mycoses (South American blastomycosis, nocardiosis, actinomycetoma) with the drug combination sulfamethoxazole+trimethoprim (bactrim, septrin). Review of the literature].
Topics: Actinomycetales; Actinomycetales Infections; Blastomyces; Blastomycosis; Dapsone; Drug Combinations; Drug Synergism; Histoplasma; Histoplasmosis; Mycoses; Nocardia; Nocardia Infections; South America; Sulfamethoxazole; Trimethoprim | 1975 |
Inhibition of dapsone-induced methaemoglobinaemia by cimetidine in the presence of trimethoprim in the rat.
Topics: Acetylation; Animals; Cimetidine; Dapsone; Drug Interactions; Half-Life; Male; Methemoglobin; Methemoglobinemia; Rats; Rats, Inbred Strains; Trimethoprim | 1992 |
New developments in the treatment of Pneumocystis carinii pneumonia.
Topics: Adrenal Cortex Hormones; Aerosols; Dapsone; Drug Therapy, Combination; Eflornithine; Folic Acid Antagonists; Humans; Pentamidine; Pneumonia, Pneumocystis; Pyrimidines; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1992 |
[Some aspects of the treatment of HIV infection].
Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Dapsone; HIV Infections; Humans; Primaquine; Trimethoprim; Trimetrexate; Zidovudine | 1991 |
In vitro susceptibilities of oxacillin-resistant Staphylococcus aureus to dapsone and sulfamethoxazole alone and in combination with trimethoprim.
Topics: Dapsone; Enterococcus faecalis; Escherichia coli; Microbial Sensitivity Tests; Oxacillin; Penicillin Resistance; Staphylococcus aureus; Sulfamethoxazole; Trimethoprim | 1990 |
In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
Topics: Adenosine Triphosphate; Animals; Chromatography, High Pressure Liquid; Dapsone; Drug Interactions; Leprostatic Agents; Leprosy; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium leprae; Receptors, Fc; Thymidine; Trimethoprim | 1990 |
Megaloblastic pancytopenia associated with dapsone and trimethoprim treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Anemia, Macrocytic; Anemia, Megaloblastic; Dapsone; Humans; Leucovorin; Pneumonia, Pneumocystis; Trimethoprim; Vitamin B 12 Deficiency | 1990 |
[Treatment and prevention of pneumocystosis].
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Anti-Bacterial Agents; Dapsone; Humans; Pneumonia, Pneumocystis; Trimethoprim | 1989 |
Megaloblastic pancytopenia associated with dapsone and trimethoprim treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Therapy, Combination; Humans; Male; Pancytopenia; Pneumonia, Pneumocystis; Trimethoprim; Vitamin B 12 Deficiency | 1989 |
Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Bronchoscopy; Dapsone; Drug Eruptions; Drug Therapy, Combination; Fever; Hematocrit; Humans; Liver; Nausea; Pneumonia, Pneumocystis; Respiratory Function Tests; Sputum; Trimethoprim | 1986 |
Treatment of Pneumocystis carinii pneumonia.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Folic Acid Antagonists; Humans; Methylprednisolone; Pentamidine; Pneumonia, Pneumocystis; Quinazolines; Recurrence; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Trimetrexate | 1987 |
Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adrenal Cortex Hormones; Adult; Anti-Infective Agents; Dapsone; Drug Combinations; Eflornithine; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Dapsone; Diminazene; Disease Models, Animal; Drug Combinations; Eflornithine; Female; Immunosuppression Therapy; Pneumonia, Pneumocystis; Random Allocation; Rats; Rats, Inbred Strains; Sulfamethoxazole; Suramin; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Inhibitors of folic acid synthesis in the treatment of experimental Pneumocystis carinii pneumonia.
Topics: Animals; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Immunosuppression Therapy; Male; Pneumonia, Pneumocystis; Pyrimethamine; Pyrimidines; Rats; Rats, Inbred Strains; Sulfadiazine; Sulfadoxine; Sulfamethoxazole; Trimethoprim | 1988 |
Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
Topics: Amidines; Animals; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Combinations; Immunosuppression Therapy; Male; Pentamidine; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Dapsone treatment of Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Dapsone; Drug Therapy, Combination; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim | 1988 |
AIDS-related Pneumocystis carinii pneumonia successfully treated with dapsone-trimethoprim.
Topics: Acquired Immunodeficiency Syndrome; Adult; Dapsone; Drug Therapy, Combination; Humans; Male; Pneumonia, Pneumocystis; Trimethoprim | 1988 |
Mycetoma of the head and neck.
Topics: Actinomycetales Infections; Adolescent; Adult; Child; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mitosporic Fungi; Mycetoma; Radiography; Skull; Streptomycin; Sudan; Sulfamethoxazole; Temporomandibular Joint; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Successful treatment and prevention of murine Pneumocystis carinii pneumonitis with 4,4'-sulfonylbisformanilide.
Topics: Animals; Dapsone; Dexamethasone; Drug Combinations; Pneumonia, Pneumocystis; Rats; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Mycetoma due to Nocardia caviae.
Topics: Dapsone; Drug Combinations; Humans; Male; Middle Aged; Mycetoma; Nocardia Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Juvenile blistering diseases: the problems of diagnosis and treatment.
Topics: Autoantibodies; Child; Child, Preschool; Complement C3; Dapsone; Dermatitis Herpetiformis; Diagnosis, Differential; Drug Combinations; Female; Fluorescent Antibody Technique; Humans; Immunoglobulin A; Immunoglobulin G; Infant; Male; Prednisolone; Skin Diseases, Vesiculobullous; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1986 |
Dapsone, trimethoprim-sulfamethoxazole, and the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Dapsone; Drug Combinations; Humans; Pneumonia, Pneumocystis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
Method of testing the susceptibility of Pneumocystis carinii to antimicrobial agents in vitro.
Topics: Animals; Cells, Cultured; Dapsone; Drug Combinations; Eflornithine; Lung; Male; Ornithine; Pentamidine; Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1985 |
[Comparative study on the effect of some clinically used sulfanilamide derivatives against toxoplasmosis in the mouse].
Topics: Aminobenzoates; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Mice; Placebos; Pyrimethamine; Structure-Activity Relationship; Sulfamerazine; Sulfamethoxazole; Sulfonamides; Time Factors; Toxoplasmosis, Animal; Trimethoprim | 1973 |
Chemotherapeutic results in a multi-drug resistant strain of Plasmodium falciparum malaria from Vietnam.
Topics: Adult; Alanine Transaminase; Anopheles; Antimalarials; Aspartate Aminotransferases; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Malaria; Male; Methylamines; Military Medicine; Phenanthrenes; Plasmodium falciparum; Pyrazines; Pyrimethamine; Quinine; Sulfanilamides; Trimethoprim; Vietnam | 1974 |
Letter: Mycetoma.
Topics: Actinomycetales Infections; Actinomycosis; Dapsone; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Immunodiffusion; Mycetoma; Streptomycin; Sudan; Sulfamethoxazole; Trimethoprim | 1974 |
A model in vitro system to test the susceptibility of human malarial parasites to antimalarial drugs.
Topics: Amodiaquine; Antimalarials; Chloroquine; Dapsone; Drug Resistance, Microbial; Microbial Sensitivity Tests; Plasmodium falciparum; Pyrimethamine; Quinine; Trimethoprim | 1972 |
Fundamental data, methods and goals of present research on the treatment of leprosy.
Topics: Animals; Animals, Laboratory; Antitubercular Agents; Clofazimine; Dapsone; Ethionamide; Humans; In Vitro Techniques; Isoniazid; Leprosy; Mice; Mycobacterium lepraemurium; Rifampin; Sulfonamides; Trimethoprim | 1973 |
[Initial clinical results using new, experimentally developed therapeutic forms in leprosy].
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Child; Dapsone; Drug Therapy, Combination; Ethiopia; Female; Histocytochemistry; Humans; Leprosy; Male; Middle Aged; Mycobacterium leprae; Rifampin; Skin; Sulfonamides; Thalidomide; Time Factors; Trimethoprim | 1973 |
Considerations on the use of sulphones and sulphonamides with a pyrimidine derivative.
Topics: Adult; Amodiaquine; Child; Dapsone; Drug Combinations; Drug Resistance, Microbial; Humans; Malaria; Mozambique; Plasmodium falciparum; Plasmodium malariae; Primaquine; Pyrimethamine; Sulfonamides; Trimethoprim | 1974 |
Some pharmacological aspects of antimalarial drugs.
Topics: Antimalarials; Chloroquine; Dapsone; Drug Resistance, Microbial; Humans; Malaria; Plasmodium falciparum; Plasmodium vivax; Primaquine; Proguanil; Pyrimethamine; Quinacrine; Quinine; Sulfonamides; Trimethoprim | 1974 |
A new analogous model for the detection and evaluation of chemotherapeutic products effective in leprosy.
Topics: Aniline Compounds; Animals; Dapsone; Disease Models, Animal; Drug Combinations; Ethionamide; Humans; Isoniazid; Leprosy; Mice; Models, Biological; Mycobacterium Infections; Phenazines; Pyrazines; Rabbits; Rifampin; Sulfonamides; Trimethoprim | 1972 |
Efficacy of diaminodiphenylsulfone and other drugs in murine Pneumocystis carinii pneumonitis.
Topics: Animals; Dapsone; Disease Models, Animal; Drug Combinations; Male; Pneumonia, Pneumocystis; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Bacterial growth kinetics of Escherichia coli and mycobacteria in the presence of brodimoprim and metioprim alone and in combination with sulfamerazine and dapsone (VI).
Topics: Anti-Bacterial Agents; Dapsone; Drug Synergism; Escherichia coli; Kinetics; Microbial Sensitivity Tests; Mycobacterium; Sulfamerazine; Trimethoprim | 1983 |
[Mycetoma in northern Argentina].
Topics: Actinomycetaceae; Adult; Aged; Argentina; Dapsone; Drug Combinations; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mitosporic Fungi; Mycetoma; Nocardia; Nocardia Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1983 |
Mechanism of action of the folate blocker diaminodiphenylsulfone (dapsone, DDS) studied in E. coli cell-free enzyme extracts in comparison to sulfonamides (SA).
Topics: 4-Aminobenzoic Acid; Dapsone; Dose-Response Relationship, Drug; Escherichia coli; Folic Acid; Folic Acid Antagonists; Kinetics; Microbial Sensitivity Tests; Mycobacterium leprae; Structure-Activity Relationship; Sulfonamides; Trimethoprim | 1980 |
A pilot study on the efficacy of epiroprim against developmental stages of Toxoplasma gondii and Pneumocystis carinii in animal models.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Therapy, Combination; Female; Folic Acid Antagonists; Male; Mice; Mice, Inbred Strains; Mice, Nude; Mice, SCID; Pilot Projects; Pneumocystis; Pneumocystis Infections; Pyrimethamine; Rats; Rats, Nude; Sodium Chloride; Sulfadiazine; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim | 1995 |
Relative potency of 10 drugs with anti-Pneumocystis carinii activity in an animal model.
Topics: Animals; Anti-Infective Agents; Atovaquone; Azithromycin; Clarithromycin; Clindamycin; Clinical Trials as Topic; Dapsone; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Naphthoquinones; Pentamidine; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Sulfadoxine; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Activity of epiroprim (Ro 11-8958), a dihydrofolate reductase inhibitor, alone and in combination with dapsone against Toxoplasma gondii.
Topics: Animals; Dapsone; Drug Synergism; Female; Folic Acid Antagonists; Mice; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim; Uracil | 1994 |
Major aphthous ulcers in patients with HIV disease.
Topics: Adult; Biomarkers; CD4-CD8 Ratio; Dapsone; Ethnicity; Female; HIV Infections; Humans; Immune Tolerance; Male; Pennsylvania; Prevalence; Prospective Studies; Risk Factors; Smoking; Stomatitis, Aphthous; Sulfamethoxazole; Trimethoprim | 1994 |
Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
Topics: AIDS-Related Opportunistic Infections; Animals; Dapsone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Folic Acid Antagonists; Immunosuppression Therapy; Male; Pneumonia, Pneumocystis; Rats; Rats, Sprague-Dawley; Sulfamethoxazole; Trimethoprim | 1993 |
Population-based estimates of antiretroviral therapy and anti-Pneumocystis prophylaxis in San Francisco: 1991.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antiviral Agents; Cohort Studies; Dapsone; Didanosine; Drug Combinations; Follow-Up Studies; HIV Infections; Humans; Male; Pentamidine; Pneumonia, Pneumocystis; San Francisco; Sulfamethizole; Trimethoprim; Zalcitabine; Zidovudine | 1993 |
Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiviral Agents; Cells, Cultured; Cytomegalovirus Infections; Dapsone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Ganciclovir; Humans; Ketoconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Species Specificity; Sulfamethoxazole; Survival Analysis; Trimethoprim; Viral Plaque Assay | 1993 |
Predictive value of bronchoalveolar lavage in excluding a diagnosis of Pneumocystis carinii pneumonia during prophylaxis with aerosolized pentamidine.
Topics: Administration, Intranasal; Adult; Aerosols; AIDS-Related Opportunistic Infections; Bronchoalveolar Lavage Fluid; Dapsone; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Pentamidine; Pneumocystis; Pneumonia, Pneumocystis; Predictive Value of Tests; Prospective Studies; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Efficacy of epiroprim (Ro11-8958), a new dihydrofolate reductase inhibitor, in the treatment of acute Toxoplasma infection in mice.
Topics: Acute Disease; Administration, Oral; Animals; Anti-Infective Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Half-Life; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Sulfadiazine; Toxoplasmosis, Animal; Trimethoprim | 1996 |
Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone.
Topics: Animals; Dapsone; Drug Combinations; Folic Acid Antagonists; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Mice; Microbial Sensitivity Tests; Sepsis; Trimethoprim | 1996 |
Combination of PS-15, epiroprim, or pyrimethamine with dapsone in prophylaxis of Toxoplasma gondii and Pneumocystis carinii dual infection in a rat model.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Immunosuppression Therapy; Pneumocystis Infections; Proguanil; Pyrimethamine; Rats; Rats, Wistar; Tetrahydrofolate Dehydrogenase; Toxoplasma; Toxoplasmosis, Animal; Trimethoprim | 1996 |
Pneumocystis carinii infection of the conjunctiva in a patient with acquired immune deficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Conjunctiva; Conjunctival Diseases; Dapsone; Eye Infections, Fungal; Fatal Outcome; Humans; Male; Pneumocystis; Pneumocystis Infections; Trimethoprim | 1997 |
In vitro activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with brodimoprim and dapsone, against Mycobacterium leprae.
Topics: Cell-Free System; Dapsone; Folic Acid Antagonists; Leprostatic Agents; Microbial Sensitivity Tests; Mycobacterium leprae; Trimethoprim | 1999 |
Antimicrobial activities of dihydrofolate reductase inhibitors, used singly or in combination with dapsone, against Mycobacterium ulcerans.
Topics: Anti-Bacterial Agents; Dapsone; Drug Therapy, Combination; Folic Acid Antagonists; Humans; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium ulcerans; Tetrahydrofolate Dehydrogenase; Trimethoprim | 2001 |
Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P carinii pneumonia in patients with HIV-1: a prospective study.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Dapsone; Dihydropteroate Synthase; Drug Resistance, Microbial; Genotype; HIV-1; Humans; Male; Middle Aged; Mutation; Pneumocystis; Pneumonia, Pneumocystis; Prognosis; Prospective Studies; Survival Analysis; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 2001 |
In vivo activity of epiroprim, a dihydrofolate reductase inhibitor, singly and in combination with dapsone, against Mycobacterium leprae.
Topics: Administration, Oral; Animals; Armadillos; Dapsone; Drug Synergism; Female; Folic Acid Antagonists; Leprostatic Agents; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Trimethoprim | 2002 |
A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim and Dapsone residues in muscle by ultra-high-performance liquid chromatography-tandem mass spectrometry accord
Topics: Animals; Anti-Bacterial Agents; Cattle; Chromatography, High Pressure Liquid; Dapsone; Drug Residues; Muscles; Poultry; Sheep; Sulfonamides; Tandem Mass Spectrometry; Tetracycline; Trimethoprim | 2009 |
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
Topics: Adult; Aged; Anemia, Hemolytic; Anti-Infective Agents; Black or African American; Cohort Studies; Dapsone; Drug Combinations; Female; Glucosephosphate Dehydrogenase; Glucosephosphate Dehydrogenase Deficiency; Hispanic or Latino; HIV Infections; Humans; Male; Middle Aged; Prevalence; Sulfamethizole; Texas; Trimethoprim; Urban Population; White People; Young Adult | 2010 |
Development of a liquid chromatography–tandem mass spectrometry method for the determination of sulfonamides, trimethoprim and dapsone in honey and validation according to Commission Decision 2002/657/EC for banned compounds [corrected].
Topics: Chromatography, Liquid; Dapsone; Food Contamination; Guidelines as Topic; Honey; Limit of Detection; Sulfonamides; Tandem Mass Spectrometry; Trimethoprim; Uncertainty | 2012 |
Feasibility of amlodipine besylate, chloroquine phosphate, dapsone, phenytoin, pyridoxine hydrochloride, sulfadiazine, sulfasalazine, tetracycline hydrochloride, trimethoprim and zonisamide in SyrSpend(®) SF PH4 oral suspensions.
Topics: Administration, Oral; Amlodipine; Chloroquine; Chromatography, High Pressure Liquid; Dapsone; Drug Stability; Drug Storage; Feasibility Studies; Hydrogen-Ion Concentration; Isoxazoles; Phenytoin; Pyridoxine; Sulfadiazine; Sulfasalazine; Suspensions; Tetracycline; Trimethoprim; Zonisamide | 2016 |
Validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous determination of sulfonamides, trimethoprim and dapsone in muscle, egg, milk and honey.
Topics: Animals; Chromatography, Liquid; Dapsone; Eggs; Honey; Milk; Muscles; Reproducibility of Results; Sulfonamides; Tandem Mass Spectrometry; Trimethoprim | 2016 |